Weight loss from Eli Lilly’s Zepbound drug can reportedly be reversed if users stop treatment, according to a new study.
In a study published in the journal JAMA, patients on the drug who struggled with non-diabetic obesity were reported to have 14 per cent weight regain nearly a year after switching to a placebo after an eight-month treatment of Zepbound. Those who weren’t given the placebo reportedly experienced an additional 5.5 per cent weight reduction throughout the 52 weeks in which data was collected.
